US Broker Ratings

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring Growth Potential with a Promising 11.77% Upside

Labcorp Holdings Inc. (NYSE: LH), a leader in the healthcare sector, specifically within diagnostics and research, presents an intriguing investment opportunity. With a market capitalization of..

Novo Nordisk A/S (NVO): Unpacking the 23% Upside Potential in Healthcare Giant’s Stock

Novo Nordisk A/S (NVO), a prominent player in the healthcare sector, stands at the forefront of innovation in drug manufacturing, particularly in the treatment of diabetes,..

Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating Growth Potential and Analyst Ratings for This Healthcare Giant

Becton, Dickinson and Company (NYSE: BDX) stands as a pivotal player in the healthcare industry, with a robust market capitalization of $48.16 billion. Founded in 1897,..

Eli Lilly and Company (LLY) Stock Analysis: Exploring a 16.27% Upside with Strong Revenue Growth

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector and a key player in the general drug manufacturing industry, has been making waves..

Cigna Group (CI) Stock Analysis: Unveiling a 26.53% Upside Potential

For individual investors eyeing opportunities in the healthcare sector, The Cigna Group (NYSE: CI) presents an intriguing proposition. With its robust market cap of $71.48 billion,..

Alcon Inc. (ALC) Stock Analysis: Eye-Catching 32.45% Upside Potential for Investors

Alcon Inc. (NYSE: ALC) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $30.82..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 23% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, is capturing investor attention with its substantial market capitalization of $57.06 billion and a..

Cencora, Inc. (COR) Stock Analysis: Exploring a 19.48% Potential Upside in the Healthcare Distribution Arena

Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector, particularly in medical distribution, is capturing investor attention with a compelling 19.48% potential upside based on..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Unveiling a 68.91% Potential Upside for Investors

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering entity in the biotechnology sector, is renowned for its innovative approach to developing therapeutics based on ribonucleic acid interference..

AstraZeneca PLC (AZN) Stock Analysis: Unveiling a 35% Potential Upside and Robust Buy Ratings

AstraZeneca PLC (AZN), a leading player in the healthcare sector, particularly within the general drug manufacturing industry, is capturing investor attention with a compelling mix of..

Elevance Health, Inc. (ELV) Stock Analysis: Unpacking a 16.81% Potential Upside Opportunity

Investors seeking opportunities in the healthcare sector may find Elevance Health, Inc. (NYSE: ELV) an intriguing prospect. With a market capitalization of $83.8 billion, this Indianapolis-based..

Stryker Corporation (SYK) Stock Analysis: Exploring a 33.54% Potential Upside Amid Robust Revenue Growth

Stryker Corporation (NYSE: SYK), a prominent player in the medical devices industry, is drawing considerable attention from investors, thanks to its promising growth prospects and a..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, renowned for its innovative approaches to tackling challenging diseases. With a market..

Danaher Corporation (DHR) Stock Analysis: Strong Buy Ratings and a 10.4% Upside Potential

Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, has captured investor attention with its robust market presence and promising growth potential. With a market..

Boston Scientific Corporation (BSX) Stock Analysis: Unpacking a 42.71% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector specializing in medical devices, offers compelling prospects for investors, underscored by a notable potential upside..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating Growth Potential with a 6.10% Upside

AbbVie Inc. (NYSE: ABBV), a prominent player in the healthcare sector, specifically in the general drug manufacturing industry, continues to capture investor interest with its robust..

MBX Biosciences (MBX) Stock Analysis: Exploring a 55.79% Potential Upside with Promising Endocrine Therapies

MBX Biosciences, Inc. (MBX), a burgeoning player in the biotechnology sector, is increasingly capturing investor attention with its promising pipeline of precision peptide therapies. As a..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Evaluating the 6.96% Potential Upside

Fortrea Holdings Inc. (FTRE), a relatively new player in the biotechnology sector, has quickly garnered attention in the investor community. The company, incorporated in 2023 and..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a Potential 68% Upside

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector with its focus on developing therapies to combat resistance mechanisms in cancer treatments. With..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 72.68% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS) is capturing investor attention with its significant potential upside of 72.68%, as indicated by the latest analyst ratings. As a prominent..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds